Ralliant (NYSE:RAL) Reaches New 52-Week High – Should You Buy?

Ralliant Corporation (NYSE:RAL)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $56.20 and last traded at $56.1470, with a volume of 28082 shares trading hands. The stock had previously closed at $54.73.

Wall Street Analysts Forecast Growth

RAL has been the subject of a number of recent analyst reports. Barclays upped their price target on shares of Ralliant from $59.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, January 7th. Truist Financial assumed coverage on Ralliant in a report on Friday, December 12th. They set a “buy” rating and a $62.00 price target on the stock. Citigroup upgraded Ralliant from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $53.00 to $61.00 in a report on Monday, December 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Ralliant in a research note on Monday, December 29th. Finally, Oppenheimer raised their price target on Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a research note on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, Ralliant presently has a consensus rating of “Moderate Buy” and an average price target of $58.00.

Ralliant Stock Up 2.5%

The firm has a market capitalization of $6.33 billion and a P/E ratio of 44.15. The company has a fifty day simple moving average of $51.78 and a 200 day simple moving average of $46.76. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.02. The company had revenue of $529.10 million during the quarter, compared to analysts’ expectations of $519.14 million.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio is currently 15.75%.

Hedge Funds Weigh In On Ralliant

Hedge funds have recently added to or reduced their stakes in the company. Ethic Inc. purchased a new stake in Ralliant during the 4th quarter valued at $767,000. Sequoia Financial Advisors LLC purchased a new stake in shares of Ralliant during the fourth quarter valued at $215,000. Danske Bank A S purchased a new stake in shares of Ralliant during the fourth quarter valued at $25,000. Oppenheimer & Co. Inc. bought a new stake in Ralliant in the 4th quarter worth about $221,000. Finally, Oppenheimer Asset Management Inc. raised its position in Ralliant by 18.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 10,725 shares of the company’s stock worth $546,000 after buying an additional 1,664 shares during the last quarter.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.